Skip to main content

Siemens Healthineers Completes Epocal Acquisition

NEW YORK (360Dx) – Siemens Healthineers said today that it completed the acquisition of Epocal from Abbott on Tuesday.

Financial and other terms of the transaction, announced in July, were not disclosed.

Siemens noted that in closing the acquisition of Epocal, the former Alere subsidiary, it has also completed its own blood-gas portfolio.

Peter Koerte, president of point-of-care diagnostics at Siemens Healthineers, said in a statement that "health networks have varying needs for blood-gas testing across physicians’ offices, clinics, emergency departments, laboratories, and even in ambulances."

He said that with a complete offering for blood-gas diagnostics, the firm can help healthcare providers and point-of-care coordinators improve their workflows "by offering the right test in the right setting at the right time.”

The firm said that in integrating Epocal's offerings into its POC Ecosystem solution, Siemens Healthineers enables customized testing — whether it involves handheld testing, benchtop solutions, or central-lab applications — that's based on the needs of an individual facility, which helps improve process efficiency.

Integrating Epocal's epoc product line will enable an "easy connection from many manufacturers’ point-of-care analyzers to hospital information systems," Siemens said.

Abbott sold Epocal in connection with a US Federal Trade Commission and European Commission review of its acquisition of Alere, which was completed in October.